Navigation Links
Cepheid Reports Fourth Quarter And Full Year 2012 Results
Date:1/24/2013

siness, continuing operational performance and cash requirements, and believes these non-GAAP measures are useful to investors as they provide a basis for evaluating the Company's cash requirements and additional insight into the underlying operating results and the Company's ongoing performance in the ordinary course of its operations.

These non-GAAP measures may be different from non-GAAP measures used by other companies.  In addition, these non-GAAP measures are not based on any comprehensive set of accounting rules or principles.  The Company believes that non-GAAP measures have limitations in that they do not reflect all of the amounts associated with its results of operations as determined in accordance with U.S. GAAP and that these measures should only be used to evaluate the Company's results of operations in conjunction with the corresponding GAAP measures.

As described above, the Company excludes the following items from one or more of its non-GAAP measures when applicable:

Litigation Settlement Expenses. These expenses consist primarily of expenses related to the settlement of our previously outstanding litigation with Abaxis.  This allocation was determined in accordance with ASC 450, Accounting for Contingencies (formerly SFAS No. 5), and ASC 605-25 (formerly EITF 00-21) using the concepts of fair value based on the past and estimated future revenue streams related to the products covered by the patents previously under dispute.  Specifically, the amount recorded in the income statement as Litigation settlement in the year ended December 31, 2012 represents the fair value of the royalty paid on past revenue streams and the residual amount after allocating value to the future revenue streams.  The Company excluded this item as it believes it is non-recurring in nature, and does not have a direct impact on the operation of the Company's core business. 

Employee Stock-based Compensatio
'/>"/>

SOURCE Cepheid
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Cepheid to Webcast Upcoming Financial Presentations
2. Cepheid Announces Executive Vice President Emerging Markets
3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
4. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
6. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
7. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
8. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
9. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
10. Luminex Corporation Reports First Quarter 2012 Results
11. Hospira Reports First-Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 2014 Imago BioSciences, Inc., a biotech ... million Series A financing led by Clarus Ventures ... team of accomplished investment and operating professionals dedicated ... round include Frazier Healthcare, Amgen Ventures, and Merck ... and Frazier Healthcare will join the company,s board ...
(Date:10/31/2014)... 2014  Lycera Corp., a biopharmaceutical company developing ... and cancer, today announced that data on the ... candidates will be presented at the annual meeting ... being held November 6-9, 2014 at the Gaylord ...  The poster, entitled " Novel synthetic RORgamma agonist ...
(Date:10/31/2014)... LONDON , October 31, 2014 ... Nanosphere Inc. (NASDAQ: NSPH ), Isis Pharmaceuticals ... (NASDAQ: HALO ), ACADIA Pharmaceuticals Inc. (NASDAQ: ... SNTA). Free research on these five companies can be ... October 30, 2014, the NASDAQ Composite ended at 4,566.14, ...
Breaking Medicine Technology:Imago BioSciences Announces $26.5 Million Financing Led by Clarus Ventures 2Lycera Announces Presentation of Data on Anti-Tumor Activity of Novel Synthetic RORgamma Agonists at Society for Immunotherapy of Cancer Meeting 2Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 2Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 3Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 4Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 5
(Date:10/31/2014)... Nearly one out of four older Americans say that ... or unwanted medical treatment, according to the latest issue ... & Aging Report ( PP&AR ), which goes ... accountable when they fail to honor patients, end-of-life health ... Advanced Illness Care: Issues and Options ," features 12 ...
(Date:10/31/2014)... Denver, Colorado (PRWEB) October 31, 2014 ... reveals that this workout program was developed by Dan ... also become well-known as a fitness professional and life ... stubborn fat and having toned muscles is not impossible ... in based on suspension training. Suspension training promises efficiency ...
(Date:10/31/2014)... drug combination that can trigger the self-destruct process in ... treatments, according to research that will be presented at ... Liverpool next week*. , When healthy cells are no ... in self destruction. But cancer cells swerve away from ... cells grow out of control – causing tumours to ...
(Date:10/31/2014)... (PRWEB) October 31, 2014 In an effort ... patients, Dr. Majid Jamali announced he will soon offer orthodontics ... by the end of November. , To build upon ... Surgery of New York has become known for, Dr. Jamali ... degrees from such top learning institutions as UCLA, Stanford and ...
(Date:10/31/2014)... BCC Research ( http://www.bccresearch.com ) reveals in its new report, ... indoor air quality (IAQ) market is expected to grow to ... (CAGR) of 7% over the next five years. The equipment ... 7.4%. , Since 2012, continuing media attention focused on ... diseases such as bird flu and the increase in chronic ...
Breaking Medicine News(10 mins):Health News:Advance directives can benefit patients, families, and health care system 2Health News:Suspension Revolution Review Reveals Dan Long's New Suspension Workout Plan 2Health News:Scientists trigger self-destruct switch in lung cancer cells 2Health News:Oral & Maxillofacial Surgery of New York Adds Orthodontic Patient Services 2Health News:Oral & Maxillofacial Surgery of New York Adds Orthodontic Patient Services 3Health News:Global Market for U.S. Indoor Air Quality (IAQ) to Reach $11.4 Billion by 2019; Equipment Market Segment Surging at 7.4% CAGR 2Health News:Global Market for U.S. Indoor Air Quality (IAQ) to Reach $11.4 Billion by 2019; Equipment Market Segment Surging at 7.4% CAGR 3
... Encouraging Families to Be Incredibly Active and Healthy, American Egg ... 13 Today, the nation,s egg farmers will delight thousands ... eggs for the 2009 White House Easter Egg Roll. ... together families to hunt for and race Easter Eggs on ...
... used tiny molecules called microRNAs to help turn adult mouse cells back to ... stem cells , they have the capacity to become any cell type in ... ... researchers has for the first time used tiny molecules called microRNAs to help ...
... lung cancer are less likely to receive recommended chemotherapy and ... no signs of lessening. That is the conclusion of a ... CANCER , a peer-reviewed journal of the American Cancer ... provide appropriate treatments for black patients and to educate them ...
... notion that females only receive finite number of eggs ... Researchers in China have demonstrated that female ovaries may ... subsequently producing offspring. , That runs counter to the ... with a finite number of the eggs or oocytes ...
... ValueRays® ergonomic computer accessories provide infrared heat therapy using infrared ... your hand pain diagnosis results in cold computer hands and ... your computer provides warmth and relief. , ... ...
... Discovery advances search for better treatments, experts say, , , ... they,ve spotted a gene variant that may raise the ... may lead to new drug treatments. , The study ... had multiple members with schizophrenia. A functional DNA change ...
Cached Medicine News:Health News:America's Egg Farmers to Participate in Annual White House Easter Egg Roll Today 2Health News:America's Egg Farmers to Participate in Annual White House Easter Egg Roll Today 3Health News:UCSF Team Closer to Creating Safe Embryonic-Like Stem Cells 2Health News:UCSF Team Closer to Creating Safe Embryonic-Like Stem Cells 3Health News:UCSF Team Closer to Creating Safe Embryonic-Like Stem Cells 4Health News:Racial disparities persist in the treatment of lung cancer 2Health News:Stem Cells Spur New Eggs in Ovaries of Adult Mice 2Health News:Stem Cells Spur New Eggs in Ovaries of Adult Mice 3Health News:Arthritis Hand Pain Relief: Infrared Heat Therapy Ergonomic Computer Workstation 2Health News:Gene Variant Tied to Schizophrenia 2
The Skirts and Vests are made with .50mm Pb in the front and .25mm Pb in the back. When worn, the overlap areas in the front of both the skirt and vest provide 1.0mm Pb protection. The velcro fastene...
Designed to fit the body and priced to fit the budget! The Economy Tie apron has a belt that wraps around the body and ties in the front. Don't let the price fool you.... this apron provides the same...
Setting a new standard in protective apparel. The unique, patented Cool-Tech™ mesh-back design fits the natural contour of the body while reducing the amount of weight carried on the shoulders ...
Features four-way apron closure for super adjustability to fit staff of all shapes and sizes. Top left and right shoulder closures allow adjustment of armhole size and chest area of apron for close a...
Medicine Products: